The results of the Merck v. Gilead lawsuit have finally been announced. In Delaware's U.S. District Court, a jury has ordered Gilead to pay Merck $2.54 billion for damage infringement. However, $2.54 billion isn't the final price, it may increase even more.
Merck wins $2.54 billion in HCV drug p... - Hepatitis C Support
Merck wins $2.54 billion in HCV drug patent infringement suit against Gilead
Written by
HFIAdmin
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
Fake Generic Harvoni
Fake Harvoni seized in Israel came from India says Swissmedic
By Gareth MacDonald+, 08-Mar-2016...
Treating myself holistically
I'm new here, i've.had hep c 35 years, treating myself with supplements
Wouldn't touch the...